Bionexus Gene Lab (BGLC) - 2024 Q3 - Quarterly Report
Bionexus Gene Lab (BGLC)2024-11-15 22:00UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ Commission File Number: 001-41750 BioNexus Gene Lab Corp. (Exact name of registrant as specified in its charter) | --- | --- | --- | |------------------ ...